---
figid: PMC7698611__ijms-21-08689-g002
figlink: pmc/articles/PMC7698611/figure/ijms-21-08689-f002/
number: F2
caption: Angiopoietin-TIE signaling under normal conditions and inflammation. (a)
  Under normal conditions, when ANG2 expression is low, ANG2 is stored in Weibel–Palade
  bodies. ANG1, which dominates ANG2 levels, binds to and activates TIE2. Along with
  co-receptor TIE1, TIE2 is phosphorylated (p-TIE2), which in turn activates phosphoinositide
  3-kinase (PI3K/AKT) signaling. Phosphorylated AKT inactivates the forkhead transcription
  factor (FOXO1) via nuclear exclusion, inhibiting further ANG2 expression. As a result,
  vessel quiescence and vascular stability are maintained. (b) In inflammation, ANG2
  is upregulated and competes with ANG1 for TIE2 receptor binding. The ectodomain
  of co-receptor TIE1 is cleaved leading to p-TIE2 suppression and PI3K/AKT inactivation.
  Consequently, activated FOXO1 increases ANG2 expression, which sustains positive
  feedback of TIE2 signaling suppression and ultimately contributes to vascular destabilization
  and leakage.
pmcid: PMC7698611
papertitle: The Angiopoietin-2 and TIE Pathway as a Therapeutic Target for Enhancing
  Antiangiogenic Therapy and Immunotherapy in Patients with Advanced Cancer.
reftext: Alessandra Leong, et al. Int J Mol Sci. 2020 Nov;21(22):8689.
pmc_ranked_result_index: '35386'
pathway_score: 0.9701296
filename: ijms-21-08689-g002.jpg
figtitle: Angiopoietin-TIE signaling under normal conditions and inflammation
year: '2020'
organisms: Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7698611__ijms-21-08689-g002.html
  '@type': Dataset
  description: Angiopoietin-TIE signaling under normal conditions and inflammation.
    (a) Under normal conditions, when ANG2 expression is low, ANG2 is stored in Weibel–Palade
    bodies. ANG1, which dominates ANG2 levels, binds to and activates TIE2. Along
    with co-receptor TIE1, TIE2 is phosphorylated (p-TIE2), which in turn activates
    phosphoinositide 3-kinase (PI3K/AKT) signaling. Phosphorylated AKT inactivates
    the forkhead transcription factor (FOXO1) via nuclear exclusion, inhibiting further
    ANG2 expression. As a result, vessel quiescence and vascular stability are maintained.
    (b) In inflammation, ANG2 is upregulated and competes with ANG1 for TIE2 receptor
    binding. The ectodomain of co-receptor TIE1 is cleaved leading to p-TIE2 suppression
    and PI3K/AKT inactivation. Consequently, activated FOXO1 increases ANG2 expression,
    which sustains positive feedback of TIE2 signaling suppression and ultimately
    contributes to vascular destabilization and leakage.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - FOXO1
  - TIE1
  - AKT2
  - AKT3
  - AKT1
  - TEK
  - PIK3CA
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3CB
  - PIK3CD
  - PIK3R5
  - PIK3R6
genes:
- word: FOXO1
  symbol: FOXO1
  source: hgnc_symbol
  hgnc_symbol: FOXO1
  entrez: '2308'
- word: FOXO1
  symbol: FOXO1
  source: hgnc_symbol
  hgnc_symbol: FOXO1
  entrez: '2308'
- word: FOXO1
  symbol: FOXO1
  source: hgnc_symbol
  hgnc_symbol: FOXO1
  entrez: '2308'
- word: TIE1
  symbol: TIE1
  source: hgnc_symbol
  hgnc_symbol: TIE1
  entrez: '7075'
- word: TIE1
  symbol: TIE1
  source: hgnc_symbol
  hgnc_symbol: TIE1
  entrez: '7075'
- word: АКТ
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: АКТ
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: АКТ
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: TIE2
  symbol: TIE2
  source: hgnc_alias_symbol
  hgnc_symbol: TEK
  entrez: '7010'
- word: TIE1
  symbol: TIE1
  source: hgnc_symbol
  hgnc_symbol: TIE1
  entrez: '7075'
- word: TIE1
  symbol: TIE1
  source: hgnc_symbol
  hgnc_symbol: TIE1
  entrez: '7075'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: АКТ
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: АКТ
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: АКТ
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: TIE2
  symbol: TIE2
  source: hgnc_alias_symbol
  hgnc_symbol: TEK
  entrez: '7010'
chemicals: []
diseases: []
figid_alias: PMC7698611__F2
redirect_from: /figures/PMC7698611__F2
figtype: Figure
---
